Evidence map›Paper›PMID 23106337›Full record

ArticleThe Biochemical journal2013

Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins.

K Alexa Orr Gandy, Daniel Canals, Mohamad Adada, Masayuki Wada, Patrick Roddy, Ashley J Snider, Yusuf A Hannun, Lina M Obeid

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

K Alexa Orr GandyDepartments of Molecular and Cellular Biology and Pathobiology, Medical University of South Carolina, Charleston, SC 29425, USA.
Daniel Canals
Mohamad Adada
Masayuki Wada
Patrick Roddy
Ashley J Snider
Yusuf A Hannun
Lina M Obeid
Stony Brook University · USMedical University of South Carolina · USNorthport VA Medical Center · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI YUSUF AWNI HANNUN · 2003 to 2026
$30.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008444 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 1992 to 2024
$12.6M
TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
CERAMIDE ACTIVATED PROTEIN PHOSPHATASESR01CA087584 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2000 to 2015
$4.2M
Role and Regulation of Ceramide Synthases in ApoptosisR01GM097741 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI LUBERTO, CHIARA · 2011 to 2019
$3.5M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
Sphingosine Phosphate Role in InflammationR01GM062887 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OBEID, LINA M · 2001 to 2009
$2.1M
Regulation and Role of Ceramidase in InflammationI01BX000156 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI OBEID, LINA M · 2009 to 2017
–
BLRD VA I01 BX000156NCI NIH HHS P01 CA097132NCI NIH HHS P01-CA97132NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA087584NCI NIH HHS R01-CA87584NCRR NIH HHS C06 RR018823NHLBI NIH HHS HL-007260NHLBI NIH HHS T32 HL007260NIGMS NIH HHS R01 GM062887NIGMS NIH HHS R01-GM062887NIGMS NIH HHS R01 GM097741NIGMS NIH HHS T32 GM008444
6 · The paper itself

Abstract

Previously we demonstrated that the sphingolipids ceramide and S1P (sphingosine 1-phosphate) regulate phosphorylation of the ERM (ezrin/radixin/moesin) family of cytoskeletal proteins [Canals, Jenkins, Roddy, Hernande-Corbacho, Obeid and Hannun (2010) J. Biol. Chem. 285, 32476-3285]. In the present article, we show that exogenously applied or endogenously generated S1P (in a sphingosine kinase-dependent manner) results in significant increases in phosphorylation of ERM proteins as well as filopodia formation. Using phosphomimetic and non-phosphorylatable ezrin mutants, we show that the S1P-induced cytoskeletal protrusions are dependent on ERM phosphorylation. Employing various pharmacological S1PR (S1P receptor) agonists and antagonists, along with siRNA (small interfering RNA) techniques and genetic knockout approaches, we identify the S1PR2 as the specific and necessary receptor to induce phosphorylation of ERM proteins and subsequent filopodia formation. Taken together, the results demonstrate a novel mechanism by which S1P regulates cellular architecture that requires S1PR2 and subsequent phosphorylation of ERM proteins.

Indexed as

AnimalsBase SequenceCell Line, TumorCell MovementCells, CulturedCytoskeletal ProteinsEzrinHeLa CellsHumansLysophospholipidsMiceMice, KnockoutMutant ProteinsNeoplasm InvasivenessPhosphorylationPseudopodiaCytoskeletal ProteinsEzrinLysophospholipidsMutant ProteinsReceptors, LysosphingolipidRNA, Small InterferingS1PR2 protein, humanSphingosinesphingosine 1-phosphatesphingosine-1-phosphate receptor-2, mouseSphingosine-1-Phosphate Receptors

Identifiers

PMID23106337
PMCPMC3623934
OpenAlexW2062358920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.